聯(lián)系電話
參考價(jià): | 面議 |
- ICE1502-0010MG 產(chǎn)品型號(hào)
- 品牌
- 生產(chǎn)商 廠商性質(zhì)
- 上海市 所在地
訪問(wèn)次數(shù):387更新時(shí)間:2023-03-15 09:24:41
- 聯(lián)系人:
- 曹女士
- 電話:
- 400-6111-883
- 手機(jī):
- 售后:
- 4006-111-883
- 傳真:
- 86-21-34615995
- 地址:
- 上海市浦東新區(qū)天雄路166弄1號(hào)3樓
- 網(wǎng)址:
- www.yeasen.com
掃一掃訪問(wèn)手機(jī)商鋪
ICE1502-Tranylcypromine Hydrochloride
Tranylcypromine Hydrochloride,>98%
【英文同義名】:2-PCPA Tranylcypromine HCl
【中文同義名】:鹽酸苯環(huán)丙胺
訂購(gòu)信息:(*,常備現(xiàn)貨)
品 牌 | 產(chǎn)品名稱(chēng) | 產(chǎn)品貨號(hào) | 規(guī) 格 | 目錄價(jià)(元) |
Gene Operation | Tranylcypromine Hydrochloride | ICE1502-0010MG | 5 mg | ¥339.00 |
ICE1502-0050MG | 10 mg | ¥869.00 | ||
ICE1502-0100MG | 100 mg | ¥1,329.00 |
產(chǎn)品描述
Tranylcypromine hydrochloride(2-PCPA)是Tranylcypromine的鹽酸鹽形式。Tranylcypromine是一種非選擇性的不可逆的單胺氧化酶(MAO)抑制劑,用作抗抑郁藥和抗焦慮藥[1]。R-(+)-Tranylcypromine, (±)-Tranylcypromine, 以及S-(?)-Tranylcypromine*抑制人類(lèi)肝微粒體中CYP2A6介導(dǎo)的尼古丁代謝,其表觀Ki值分別為0.05 μM, 0.08 μM,和2.0 μM[1]。Tranylcypromine (500 μg/mL)嚴(yán)重抑制小牛主動(dòng)脈內(nèi)皮細(xì)胞中緩激肽受激的花生四烯酸釋放[2]。Tranylcypromine抑制人類(lèi)肝微粒體中CYP2A6和CYP2E1的活性,其IC50分別為0.42 μM和3 μM。Tranylcypromine引起人類(lèi)肝微粒體中II型和環(huán)丙基苯I型的差光譜[3]。體內(nèi)研究中,與鹽水對(duì)照組相比,5 mg/kg和10 mg/kg的Tranylcypromine注射會(huì)導(dǎo)致雄性大鼠的肌肉活動(dòng)大而緩慢的增加,雖然2 mg/kg的Tranylcypromine不會(huì)誘導(dǎo)其增加。Tranylcypromine (10 mg/kg)也會(huì)引起雄性大鼠飼養(yǎng)行為數(shù)量的顯著增加[4] 。
靶點(diǎn)
靶點(diǎn) | MAO | CYP2A6 |
IC50(半數(shù)有效濃度) | 80 nM(Ki) [1] |
化學(xué)特性
Cas No.: 1986-47-6 | 分子量: 169.65 |
分子式: C9H12ClN | 純度: >98% |
同義名: 2-PCPA Tranylcypromine HCl | |
化學(xué)名: trans-2-phenylcyclopropylamine hydrochloride | |
外觀: 結(jié)晶固體 | |
溶解: 溶于DMSO (up to 100 mM) | |
保存:3年 -20℃粉狀 |
儲(chǔ)存液配制
儲(chǔ)存液 (1 ml DMSO體系) | 1 mM | 5 mM | 10 mM | 25 mM | 50 mM | 100 mM |
質(zhì)量(mg) | 0.1697 | 0.8483 | 1.6965 | 4.2413 | 8.4825 | 16.9650 |
結(jié)構(gòu)式
使用濃度(僅作參考)
Tranylcypromine Hydrochloride的具體使用濃度請(qǐng)參考相關(guān)文獻(xiàn),并根據(jù)自身實(shí)驗(yàn)條件(如實(shí)驗(yàn)?zāi)康?,?xì)胞種類(lèi),培養(yǎng)特性等)進(jìn)行摸索和優(yōu)化。
參考文獻(xiàn)
[1] Zhang W, et al. Evaluation of methoxsalen, tranylcypromine, and tryptamine as specific and selective CYP2A6 inhibitors in vitro. Drug Metab Dispos. 29(6):897-902(2001).
[2] Hong SL, et al. Tranylcypromine and 15-hydroperoxyarachidonate affect arachidonic acid release in addition to inhibition of prostacyclin synthesis in calf aortic endothelial cells. J Biol Chem. 255(20):9538-40(1980).
[3] Taavitsainen P, et al. In vitro inhibition of cytochrome P450 enzymes in human liver microsomes by a potent CYP2A6 inhibitor, trans-2-phenylcyclopropylamine (tranylcypromine), and its nonamine analog, cyclopropylbenzene. Drug Metab Dispos. 29(3):217-22 (2001).
[4] Negishi T, et al. Behavioral alterations in response to fear-provoking stimuli and tranylcypromine induced by perinatal exposure to bisphenol A and nonylphenol in male rats. Environ Health Perspect. 112(11):1159-64 (2004).